menu
    • menu

    Company profile for Aclaris Therapeutics

    NEW Drugs in Dev: 15
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since Aclaris was founded in 2012, our focus has been innovation to help people with underserved dermatologic conditions, taking inspiration from some of the patients our founders saw in clinical practice as dermatologists. We're identifying early-stage drug candidates to create novel medicines for skin and hair disorders. We've built a committed, patient-centric organization of nearly 200 employees, guided by leaders with ...
    Since Aclaris was founded in 2012, our focus has been innovation to help people with underserved dermatologic conditions, taking inspiration from some of the patients our founders saw in clinical practice as dermatologists. We're identifying early-stage drug candidates to create novel medicines for skin and hair disorders. We've built a committed, patient-centric organization of nearly 200 employees, guided by leaders with 250+ years of combined experience in developing and commercializing treatments in dermatology and immunology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aclaris TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    640 Lee Road Suite 200 Wayne, PA 19087
    Telephone
    Telephone
    (484) 324-7933
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aclaristx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aclaris ITK/JAK3 Inhibitor Shows Hair Regrowth in Alopecia Model
    Aclaris ITK/JAK3 Inhibitor Shows Hair Regrowth in Alopecia Model

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226283/37216/en/Aclaris-Therapeutics-Novel-ITK-JAK3-Inhibitor-ATI-2138-Demonstrates-Rapid-and-Sustained-Hair-Regrowth-in-Validated-Murine-Model-of-Alopecia-Areata-AA.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Aclaris Starts ATI-052 Phase 1b POC Trial in Atopic Dermatitis
    Aclaris Starts ATI-052 Phase 1b POC Trial in Atopic Dermatitis

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216681/37216/en/Aclaris-Therapeutics-Initiates-Phase-1b-Proof-of-Concept-Trial-in-Atopic-Dermatitis-AD-with-Its-Novel-Bispecific-Antibody-ATI-052.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Aclaris Therapeutics Reports Positive Phase 1A Results
    Aclaris Therapeutics Reports Positive Phase 1A Results

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213432/37216/en/Aclaris-Therapeutics-Announces-Positive-Interim-Results-of-Phase-1a-Trial-of-Anti-TSLP-IL-4R%CE%B1-Bispecific-Antibody-ATI-052-Supporting-Expedited-Clinical-Development.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Aclaris Therapeutics Added to the NASDAQ Biotechnology Index
    Aclaris Therapeutics Added to the NASDAQ Biotechnology Index

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208727/37216/en/Aclaris-Therapeutics-Added-to-the-NASDAQ-Biotechnology-Index-NBI.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Aclaris Therapeutics Joins Piper Sandler Healthcare Conference
    Aclaris Therapeutics Joins Piper Sandler Healthcare Conference

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194260/37216/en/Aclaris-Therapeutics-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Aclaris Therapeutics Joins Three November Healthcare Conferences
    Aclaris Therapeutics Joins Three November Healthcare Conferences

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176312/37216/en/Aclaris-Therapeutics-to-Participate-in-Three-November-Healthcare-Conferences.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search